Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 4 Unknown 2 Terminated 2 Completed 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8 Sarcoma, Ewing 3 Osteosarcoma 3 Thyroid Neoplasms 1 Solid Malignant Tumors 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gastrointestinal Stromal Tumors 1 Esophageal Neoplasms 1 Chondrosarcoma 1 Chondroma 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Bone Neoplasms 1 Advanced Colorectal Cancer 1 Advanced Biliary Tract Cancer 1 Adenocarcinoma 1

Interventions

Capecitabine 13 Fluorouracil 12 Oxaliplatin 9 Nivolumab 9 Radiotherapy 8 Leucovorin 8 Cetuximab 8 Magnetic Resonance Spectroscopy 6 Irinotecan 5 pembrolizumab 4 encorafenib 4 Surgical Procedures, Operative 4 Sigmoidoscopy 4 Radiotherapy, Intensity-Modulated 4 Surveys and Questionnaires 3 Standard of Care 3 Specimen Handling 3 Biopsy 3 Bevacizumab 3 dostarlimab 2 dehydroftorafur 2 atezolizumab 2 XELOX 2 X-Rays 2 Observation 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Folfox protocol 2 Drug Therapy 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rectal Neoplasms × regorafenib × Clear all

NCT04503694 2026-05-22

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡